Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

NCT04974671 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Oligoprogressive
Progression

Interventions

RADIATION: Stereotactic Body Radiation Therapy

Sponsor

Yale University